EC Pulmonology and Respiratory Medicine

Review Article Volume 12 Issue 8 - 2023

History and Mystery of Pulmonary Surfactant Membranes

RaghavendraRao MV1*, AbdurRahman2 and Chennamchetty Vijay Kumar3

1Scientist Emeritus, Director of Research Laboratory, Apollo Institute of Medical Sciences and Research, Hyderabad, TS, India

2Consultant Biochemist, Vijaya Diagnostic Centre, Himayat Nagar, Hyderabad, TS, India

3Professor, Department of Pulmonary Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, TS, India

*Corresponding Author: Raghavendra Rao MV, Scientist Emeritus, Director of Research Laboratory, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India.
Received: August 15, 2023; Published:September 04, 2023



The lung is a complicated organ. Lungs play a pivotal walk on part in safeguarding cellular respiration. The lung epithelium is concealed by pulmonary surfactant, which is an intricate membranous proteolipid film that keeps going lung function.

Epithelial alveolar type 2 cells secrete alveolar epithelium. Pulmonary surfactant is the first respiratory barrier against inhaled foreign matter and microorganisms. This pulmonary surfactant lessens surface tension.

Pulmonary surfactant deficiency is associated with respiratory pathologies, and treatment often includes supplementation with exogenous materials.

The respiratory membrane contains type 1, and type 11 Alveolar epithelial cells, endothelial and fibroblasts. Pulmonary surfactant (PS) is a lipid-protein complex essential to stabilize the alveoli.

 Keywords: Type 1 and Type 11 Alveolar Epithelial Cells; Endothelial; Fibroblasts; Extracorporeal Membrane Oxygenation

  1. Guillot L., et al. “Alveolar Epithelial Cells: Master Regulators of Lung Homeostasis”. The International Journal of Biochemistry and Cell Biology 45 (2013): 2568-2573.
  2. Losa D and Chanson M. “The Lung Communication Network”. Cellular and Molecular Life Sciences 72 (2015): 2793-2808.
  3. Amann A and Smith D. “Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine”. Amsterdam: Elsevier (2013).
  4. Pociask DA., et al. “Epigenetic and transcriptomic regulation of lung repair during recovery from influenza infection”. The American Journal of Pathology 187 (2017): 851-863.
  5. Zacharias WJ., et al. “Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor”. Nature 555 (2018): 251-255.
  6. , et al. “Physiological Basis of Extracorporeal Membrane Oxygenation and Extracorporeal Carbon Dioxide Removal in Respiratory Failure”. Barbara Ficials 11.3 (2021): 225.
  7. Yang J., et al. “The development and plasticity of alveolar type 1 cells”. Development 143 (2016): 54-65.
  8. Kim KJ and Malik AB. “Protein transport across the lung epithelial barrier”. The American Journal of Physiology-Lung Cellular and Molecular Physiology 284 (2003): L247-L259.
  9. Cabrera-Benitez NE., et al. “Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition”. Critical Care Medicine 40 (2012): 510-517.
  10. Pu Mao., et al. “Human alveolar epithelial type II cells in primary culture”. Physiological Reports2 (2015): e12288.
  11. Aleksandra Majewska., et al. “Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies”. International Journal of Molecular Sciences2 (2021): 520.
  12. Sumpio BE., et al. “Cells in focus: Endothelial cell”. The International Journal of Biochemistry and Cell Biology 34 (2002): 1508-1512.
  13. George Makdisi and Wen Wang. “Corporeal Membrane Oxygenation (ECMO) review of lifesaving technology”. Journal of Thoracic Disease7 (2015): EExtra166-E176.
  14. Nika Marušič Ziliang Zhao and Rumiana Dimova. “Constructing artificial respiratory chain in polymer compartments: Insights into the interplay between bo3 oxidase and the membrane”. Edited by Michael L. Klein, Temple University, Philadelphia 117.26 (2020) 15006-15017.
  15. Sung H., et al. “Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians3 (2021): 209-249.
  16. Sontheimer-Phelps A., et al. “Modelling cancer in microfluidic human organs-on-Chips”. Nature Reviews Cancer2 (2019): 65-81.
  17. Liu W., et al. “Akr1b10 (Aldo-ketoreductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model”. Actabiomater 91 (2019): 195-208.
  18. Zhang M., et al. “Biomimetic human disease model of sars-Cov-2-Induced lung injury and immune responses on organ chip system”. Advanced Science3 (2021): 2002928.
  19. Doryab A., et al. “Real-time measurement of cell mechanics as a clinically relevant readout of an in vitro lung fibrosis model established on a bioinspired basement membrane”. Advanced Materials41 (2022): e2205083.
  20. Guan M., et al. “Development of alveolar-Capillary-Exchange (Ace) chip and its application for assessment of Pm2.5-induced toxicity”. Ecotoxicology and Environmental Safety 223 (2021): 112601.
  21. H Halliday. “Surfactants: past, present, and future”. Journal of Perinatology 28 (2008): S47-S56.
  22. D Willson TNJMBP. “Effect of exogenous surfactant (calf actant) in pediatric acute lung injury: a randomized controlled trial”. The Journal of the American Medical Association 293 (2005): 470-476.
  23. Doryab A., et al. “Real-time measurement of cell mechanics as a clinically relevant readout of an in vitro lung fibrosis model established on a bioinspired basement membrane”. Advanced Materials41 (2022): e2205083.
  24. Nam H., et al. “Modular assembly of bioprintedperfusable blood vessel and tracheal epithelium for studying inflammatory respiratory diseases”. Biofabrication1 (2022): 014101.
  25. Zhang B., et al. “Advances in organ-on-a-Chip engineering”. Nature Reviews Materials8 (2018): 257-278.
  26. Barbara Ruaro., et al. “The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung”. International Journal of Molecular Sciences5 (2021): 2566.
  27. Lopez-Rodriguez E and Perez-Gil J. “Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy”. Biochimica et Biophysica Acta 1838 (2014): 1568-1585.
  28. Beers MF and Moodley Y. “When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine”. American Journal of Respiratory Cell and Molecular Biology 57 (2017): 18-27.
  29. N Ban., et al. “ABCA3 as a lipid transporter in pulmonary surfactant biogenesis”. Journal of Biological Chemistry 282 (2007): 9628-9634.
  30. A Ravasio., et al. “Pérez-Gil Lamellar bodies form solid three-dimensional films at the respiratory air-liquid interface”. Journal of Biological Chemistry 285 (2010): 28174-28182.
  31. Wynn TA., et al. “Macrophage biology in development, homeostasis, and disease”. Nature7446 (2013): 445-455.
  32. Pragyan Ray., et al. “Surface Engineering of a Bioartificial Membrane for Its Application in Bioengineering Devices”. ACS Omega4 (2023): 3606-3629.
  33. Wiese F. “Membranes for Artificial Lung and Gas Exchange Applications”. Biomedical Membranes and (Bio)artificial Organs (2018): 83-104.
  34. Vienken J. “Membranes for Artificial Kidneys”. Biomedical Membranes and (Bio) Artificial Organs (2018): 35-58.
  35. NikaMarušič., et al. “Constructing artificial respiratory chain in polymer compartments: Insights into the interplay between bo3 oxidase and the membrane”. Proceedings of the National Academy of Sciences of the United States of America (2020).
  36. Harasimowicz M., et al. “Application of polyimide membranes for biogas purification and enrichment”. Journal of Hazardous Materials 144 (2007): 698-702.
  37. Yang J., et al. Polymer-Based Membranes for C3+ Hydrocarbon Removal from Natural Gas; Intech Open: London, UK (2022).
  38. Rahman WAWA., et al. “Formation and Characterization of Mixed Matrix Composite Materials for Efficient Energy Gas Separation”. Universiti Teknologi Malaysia: Johor Bahru, Malaysia (2006).
  39. JD Sirard., et al. “Relaxation dynamics of CO2 diffusion, sorption, and polymer swelling for plasticized polyimide membranes”. Macromolecules 36 (2003): 6442-6448.
  40. De Meis D., et al. “Inorganic membranes for gas separation and purification”. The InterCeram: International Ceramic Review 67 (2018): 16-21.
  41. Chung TS., et al. “Mixed matrix membranes (MMMs) comprising organic polymers with dispersed inorganic fillers for gas separation”. Progress in Polymer Science 32 (2007): 483-507.
  42. Kim JF., et al. “Thermally induced phase separation and electrospinning methods for emerging membrane applications: A review”. The AIChE Journal 62 (2016): 461-490.
  43. Zito PF., et al. “Discrimination among gas translation, surface and Knudsen diffusion in permeation through zeolite membranes”. Journal of Membrane Science 564 (2018): 166-173.
  44. James Doyle and Jeffrey S Cooper. “Physiology, Carbon Dioxide Transport, National center for, Biotechnology Information”. NIH (2022).
  45. Hsia CC. “Respiratory function of hemoglobin”. The New England Journal of Medicine4 (1998): 239-247.
  46. Comellini V., et al. “Benefits of non-invasive ventilation in acute hypercapnic respiratory failure”. Respirology4 (2019): 308-317.
  47. Frat JP., et al. “Non-invasive ventilation or high-flow oxygen therapy: When to choose one over the other?” Respirology8 (2019): 724-731.

Raghavendra Rao MV., et al. "History and Mystery of Pulmonary Surfactant Membranes". EC Pulmonology and Respiratory Medicine  12.8 (2023): 01-10.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net